Anne Langsted

10.7k total citations · 3 hit papers
77 papers, 4.4k citations indexed

About

Anne Langsted is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Anne Langsted has authored 77 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Surgery, 45 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Cancer Research. Recurrent topics in Anne Langsted's work include Lipoproteins and Cardiovascular Health (58 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Cancer, Lipids, and Metabolism (22 papers). Anne Langsted is often cited by papers focused on Lipoproteins and Cardiovascular Health (58 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Cancer, Lipids, and Metabolism (22 papers). Anne Langsted collaborates with scholars based in Denmark, United Kingdom and United States. Anne Langsted's co-authors include Børge G. Nordestgaard, Pia R. Kamstrup, J Freiberg, Anette Varbo, Martin Bødtker Mortensen, Anne Tybjærg‐Hansen, Camilla Ditlev Lindhardt Johannesen, Takahito Doi, Shoaib Afzal and Marianne Benn and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anne Langsted

72 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

2016 387 citations Børge G. Nordestgaard, Anne Langsted profile →
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

2021 204 citations Camilla Ditlev Lindhardt Johannesen, Martin Bødtker Mortensen et al. Journal of the American College of Cardiology profile →
Lipoprotein(a) and cardiovascular disease

2024 72 citations Børge G. Nordestgaard, Anne Langsted The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Langsted Denmark	33	3.0k	1.9k	1.5k	937	535	77	4.4k
Anette Varbo Denmark	34	3.5k 1.2×	3.2k 1.7×	1.9k 1.3×	1.2k 1.3×	943 1.8×	57	5.8k
Albert Wiegman Netherlands	37	3.8k 1.2×	1.8k 1.0×	1.7k 1.1×	944 1.0×	233 0.4×	144	5.1k
George Thanassoulis Canada	42	2.3k 0.7×	1.1k 0.6×	2.6k 1.7×	482 0.5×	635 1.2×	149	5.3k
Patrick M. Moriarty United States	35	3.1k 1.0×	1.3k 0.7×	1.3k 0.8×	829 0.9×	320 0.6×	109	4.8k
Masa‐aki Kawashiri Japan	35	2.4k 0.8×	1.2k 0.6×	1.5k 1.0×	714 0.8×	473 0.9×	286	4.6k
David D. Waters United States	22	3.5k 1.1×	1.7k 0.9×	1.4k 0.9×	662 0.7×	333 0.6×	37	4.8k
Jeanine E. Roeters van Lennep Netherlands	33	1.6k 0.5×	885 0.5×	1.2k 0.8×	482 0.5×	234 0.4×	182	3.8k
Craig Granowitz United States	18	1.6k 0.5×	1.3k 0.7×	1.0k 0.7×	285 0.3×	342 0.6×	55	3.2k
Michael C dʼEmden Australia	22	2.4k 0.8×	2.9k 1.5×	1.1k 0.7×	473 0.5×	512 1.0×	72	5.4k
Jackie A. Cooper United Kingdom	44	1.6k 0.5×	1.2k 0.7×	1.5k 1.0×	512 0.5×	645 1.2×	123	5.6k

Countries citing papers authored by Anne Langsted

Since Specialization

Citations

This map shows the geographic impact of Anne Langsted's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Langsted with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Langsted more than expected).

Fields of papers citing papers by Anne Langsted

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Langsted. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Langsted. The network helps show where Anne Langsted may publish in the future.

Co-authorship network of co-authors of Anne Langsted

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Langsted. A scholar is included among the top collaborators of Anne Langsted based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Langsted. Anne Langsted is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Afzal, Shoaib, Børge G. Nordestgaard, Per Ejlstrup Sigvardsen, et al.. (2025). Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population Study. European Journal of Preventive Cardiology. 32(17). 1741–1750.

Malick, Waqas, Daein Choi, Anne Langsted, et al.. (2025). Challenges in achieving LDL cholesterol targets and novel approaches to lipid lowering. European Journal of Preventive Cardiology. 32(13). 1136–1144. 2 indexed citations

Johannesen, Camilla Ditlev Lindhardt, Martin Bødtker Mortensen, Børge G. Nordestgaard, & Anne Langsted. (2025). Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation. Atherosclerosis. 403. 119139–119139. 5 indexed citations

Johannesen, Camilla Ditlev Lindhardt, Anne Langsted, Børge G. Nordestgaard, & Martin Bødtker Mortensen. (2024). Excess Apolipoprotein B and Cardiovascular Risk in Women and Men. Journal of the American College of Cardiology. 83(23). 2262–2273. 20 indexed citations

Balling, Mie, Shoaib Afzal, Anette Varbo, Børge G. Nordestgaard, & Anne Langsted. (2024). Remnant Cholesterol: Quantification, Concentrations by Sex and Age, and Risk of Ischemic Heart Disease. Clinical Chemistry. 71(4). 451–462. 2 indexed citations

Langsted, Anne, et al.. (2024). Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study. Atherosclerosis. 399. 118625–118625.

Kamstrup, Pia R., et al.. (2024). High Lipoprotein(a) as a Cause of Kidney Disease. Journal of the American College of Cardiology. 84(24). 2407–2410. 4 indexed citations

Nordestgaard, Børge G. & Anne Langsted. (2024). Lipoprotein(a) and cardiovascular disease. The Lancet. 404(10459). 1255–1264. 72 indexed citations breakdown →

Balling, Mie, Shoaib Afzal, George Davey Smith, et al.. (2023). Elevated LDL Triglycerides and Atherosclerotic Risk. Journal of the American College of Cardiology. 81(2). 136–152. 63 indexed citations

10.

Langsted, Anne, et al.. (2023). Statin use and reduced STEMI relative to non-STEMI: A nationwide study in denmark. Atherosclerosis. 379. S41–S42. 1 indexed citations

11.

Doi, Takahito, Anne Langsted, & Børge G. Nordestgaard. (2023). Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality. Atherosclerosis. 379. 117141–117141. 36 indexed citations

12.

Mortensen, Martin Bødtker, et al.. (2022). Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study. Atherosclerosis. 355. 76–82. 66 indexed citations

13.

Langsted, Anne & Børge G. Nordestgaard. (2022). Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia. Current Atherosclerosis Reports. 24(4). 289–296. 11 indexed citations

14.

Johannesen, Camilla Ditlev Lindhardt, Martin Bødtker Mortensen, Anne Langsted, & Børge G. Nordestgaard. (2021). Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology. 77(11). 1439–1450. 204 indexed citations breakdown →

15.

Langsted, Anne, Stig E. Bojesen, Erik S.G. Stroes, & Børge G. Nordestgaard. (2020). AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers. Atherosclerosis. 312. 8–15. 10 indexed citations

16.

Johannesen, Camilla Ditlev Lindhardt, Anne Langsted, Martin Bødtker Mortensen, & Børge G. Nordestgaard. (2020). Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ. 371. m4266–m4266. 167 indexed citations

17.

Langsted, Anne, Børge G. Nordestgaard, & Pia R. Kamstrup. (2019). Elevated Lipoprotein(a) and Risk of Ischemic Stroke. Journal of the American College of Cardiology. 74(1). 54–66. 160 indexed citations

18.

Langsted, Anne, Pia R. Kamstrup, & Børge G. Nordestgaard. (2018). High lipoprotein(a) and high risk of mortality. European Heart Journal. 40(33). 2760–2770. 168 indexed citations

19.

Nordestgaard, Børge G., Stephen J. Nicholls, Anne Langsted, Kausik K. Ray, & Anne Tybjærg‐Hansen. (2018). Advances in lipid-lowering therapy through gene-silencing technologies. Nature Reviews Cardiology. 15(5). 261–272. 106 indexed citations

20.

Langsted, Anne, J Freiberg, & Børge G. Nordestgaard. (2016). Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004–2014. Atherosclerosis. 257. 9–15. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact